Adverse Pregnancy Outcomes Associated With in Utero Exposure to Multiple Sclerosis Disease-Modifying Therapies in France: A Nationwide Cohort Study

被引：0
|
作者：
Swital, Morgane [1 ]
Drouin, Jerome [1 ]
Miranda, Sara [2 ]
Botton, Jeremie [1 ]
Dray-Spira, Rosemary [1 ]
机构：
[1] EPI PHARE, French Natl Agcy Med & Hlth Prod Safety ANS, French Natl Hlth Insurance CNAM, 143-147 Blvd Anatole France, F-93285 St Denis, France
[2] EPI PHARE, ANSM, CNAM, Paris, France
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
190
引用
收藏
页码：61 / 62
页数：2
相关论文
共 50 条
  • [21] DISEASE-MODIFYING THERAPIES FOR MULTIPLE-SCLEROSIS
    CARTER, JL
    CNS DRUGS, 1995, 3 (02) : 99 - 114
  • [22] Emerging Disease-Modifying Therapies in Multiple Sclerosis
    Perumal, Jai
    Khan, Omar
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2012, 14 (03) : 256 - 263
  • [23] Adherence to Disease-Modifying Therapies for Multiple Sclerosis
    Higuera, Lucas
    Carlin, Caroline S.
    Anderson, Sarah
    Journal of Managed Care & Specialty Pharmacy, 2016, 22 (12): : 1394 - 1401
  • [24] Update on disease-modifying therapies for multiple sclerosis
    Vargas, Diana L.
    Tyor, William R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (05) : 883 - 891
  • [25] Emerging Disease-Modifying Therapies in Multiple Sclerosis
    Jai Perumal
    Omar Khan
    Current Treatment Options in Neurology, 2012, 14 : 256 - 263
  • [26] Multiple Sclerosis, Disease-Modifying Therapies, and Infections
    Langer-Gould, Annette M.
    Smith, Jessica B.
    Gonzales, Edlin G.
    Piehl, Fredrik
    Li, Bonnie H.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (06):
  • [27] Oral Disease-Modifying Therapies for Multiple Sclerosis
    Kim, Woojun
    Zandona, Manuella Edler
    Kim, Su-Hyun
    Kim, Ho Jin
    JOURNAL OF CLINICAL NEUROLOGY, 2015, 11 (01): : 9 - 19
  • [28] Using disease-modifying therapies for multiple sclerosis
    不详
    JOURNAL OF ADVANCED NURSING, 2004, 48 (03) : 314 - 314
  • [29] Current disease-modifying therapies in multiple sclerosis
    Kieseier, BC
    Hartung, HP
    SEMINARS IN NEUROLOGY, 2003, 23 (02) : 133 - 145
  • [30] The influence of disease-modifying therapies on neuropsychiatric outcomes in people with multiple sclerosis
    Freedman, David
    Oh, Jiwon
    Feinstein, Anthony
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1125 - 1125
12345